Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Oncology Reports|October 26, 2011
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) studyDimitrios Pectasides, George Papaxoinis, Vassiliki Kotoula, et al.
Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.
Plos One|May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trialGeorge Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.
Breast Cancer Research and Treatment|March 22, 2012
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFlorentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, et al.
Anticancer Research|December 1, 2022
Genetic Predisposition to Male Breast Cancer: A Case SeriesAngela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, et al.
The Lancet. Oncology|June 16, 2025
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trialNeeraj Agarwal, Arun A Azad, Joan Carles, et al.
Anticancer Research|January 2, 2020
Management of Cancer-associated Thrombosis (CAT): Symptomatic or IncidentalPavlos Papakotoulas, Nikolaos Tsoukalas, Athina Christopoulou, et al.
Cancers|July 19, 2020
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?Nikolaos Tsoukalas, Pavlos Papakotoulas, Athina Christopoulou, et al.
British Journal of Cancer|March 27, 2020
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trialCesare Gridelli, Tudor Ciuleanu, Manuel Domine, et al.
Lancet (London, England)|July 11, 2021
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trialChristopher Sweeney, Sergio Bracarda, Cora N Sternberg, et al.
Pageof 4